Skip to main content

Articles

Page 171 of 209

  1. Depressive disorders are highly prevalent and result in negative consequences for both patients and society. It is therefore important that these disorders are treated adequately. However, due to increased dem...

    Authors: Robin Maria Francisca Kenter, Annemieke van Straten, Sabine Heleen Hobbel, Filip Smit, Judith Bosmans, Aartjan Beekman and Pim Cuijpers
    Citation: Trials 2013 14:412
  2. Medication non-adherence is considered an important cause of morbidity and mortality in primary care. This study aims to determine the effectiveness, cost effectiveness and acceptability of a complex intervent...

    Authors: Matthew Boyd, Justin Waring, Nick Barber, Rajnikant Mehta, Antony Chuter, Anthony J Avery, Nde-Eshimuni Salema, James Davies, Asam Latif, Lukasz Tanajewski and Rachel A Elliott
    Citation: Trials 2013 14:411
  3. The burden of cardiovascular disease is rising in sub-Saharan Africa with hypertension being the main risk factor. However, context-specific evidence on effective interventions for primary prevention of cardio...

    Authors: Samuel O Oti, Steven JM van de Vijver, Catherine Kyobutungi, Gabriela B Gomez, Charles Agyemang, Eric P Moll van Charante, Lizzy M Brewster, Marleen E Hendriks, Constance Schultsz, Remare Ettarh, Alex Ezeh and Joep Lange
    Citation: Trials 2013 14:409
  4. Cardiovascular complications are the leading cause of mortality and morbidity in Marfan syndrome (MFS), a dominantly inherited disorder caused by mutations in the gene that encodes fibrillin-1. There are appro...

    Authors: Michael J Mullen, Marcus D Flather, Xu Yu Jin, William G Newman, Guliz Erdem, David Gaze, Oswaldo Valencia, Winston Banya, Claire E Foley and Anne Child
    Citation: Trials 2013 14:408
  5. Authors: Cherry-Ann Waldron, Emma Thomas-Jones, Timothy Pickles, Kerry Hood, Kim Harman, Harriet Downing, Kate Martinson, Marilyn Peters, Alastair D Hay and Christopher C Butler
    Citation: Trials 2013 14(Suppl 1):P37

    This article is part of a Supplement: Volume 14 Supplement 1

  6. Authors: Trudie Lang, Mike Clarke, Melanie Newport, Fikre Enquoselassie, Francois van Loggerenberg, Sam Franzen, Tamzin Furtado, Patricia Njuguna, Greg Fegan and Gail Davey
    Citation: Trials 2013 14(Suppl 1):O31

    This article is part of a Supplement: Volume 14 Supplement 1

  7. Authors: Janine Bates, Emma Thomas-Jones, Nigel Kirby, Tim Pickles, Rhys Thomas, Emily Bongard, Micaela Gal, Paul Little, Theo Verheij, Carlos Llor, David Cohen, Nick Francis, Kerry Hood and Christopher Butler
    Citation: Trials 2013 14(Suppl 1):P10

    This article is part of a Supplement: Volume 14 Supplement 1

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    2.5 - 5-year Impact Factor
    0.827 - SNIP (Source Normalized Impact per Paper)
    0.814 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    6,282,238 downloads
    5,569 Altmetric mentions